FDA approves second gene therapy, Zolgensma, to treat spinal muscular atrophy in infants

At $2,125,000, it is the most expensive drug in the world

Source: Chemical and Engineering News - May 31, 2019 Category: Chemistry Authors: Ryan Cross  Source Type: research